Baseline severe disability as a predictor of treatment escalation to rituximab in AQP4-IgG–positive NMOSD patients: A retrospective cohort study

Multiple Sclerosis and Related Disorders 2026

View at publisher

Authors: Chayangkoon Siripornmongkol, Metha Apiwattanakul, Saharat Aungsumart

DOI: 10.1016/j.msard.2026.107022

Cited by: 0

References: 52

Fields of Study & Subjects

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Polyomavirus and related diseases

References 52